Latest Distribution Agreements News

Metcash Limited reported solid FY25 financial results with revenue growth and market share gains across key pillars, underpinned by strategic acquisitions and operational improvements. The company enters FY26 with positive momentum and ongoing transformation initiatives.

Sprintex Limited has boosted its Türkiye presence by extending its exclusive distribution deal, securing a new A$377,000 order, and launching larger Jet Blowers aimed at industrial and municipal markets.

RLF AgTech has secured exclusive rights to distribute AXIOMA Biologicals’ advanced biostimulant products across Australia, China, and Asia, marking a strategic move into the biologicals market segment.

EZZ Life Science has inked a three-year distribution deal with ROFA Enterprises, marking a significant step into Southeast Asia’s booming health market. The agreement guarantees at least A$21 million in sales across Thailand, Vietnam, and Singapore.

TruScreen Group Limited forecasts a robust 64% increase in FY26 sales, driven by strategic market expansions and new distribution agreements. The company’s AI-enabled cervical cancer screening technology is gaining traction across emerging markets.

LTR Pharma has expanded patient access to its fast-acting erectile dysfunction treatment SPONTAN by partnering with TerryWhite Chemmart’s extensive pharmacy network, marking a significant step in its commercial rollout and regulatory strategy.

Streamplay Studio Limited has inked an exclusive agreement to bring its cloud gaming service to Sri Lanka’s largest mobile network, Dialog Axiata, targeting over 19 million subscribers. This expansion follows its recent successful launch in the UAE, positioning Streamplay for growth in emerging mobile-first markets.

Insurance Australia Group (IAG) has entered a strategic alliance with The Royal Automobile Club of Western Australia (RAC), acquiring RAC Insurance and securing a 20-year exclusive distribution agreement. This move significantly boosts IAG's presence in Western Australia and is expected to enhance earnings and operational synergies.

Universal Biosensors reports solid growth in its wine testing segment and outlines plans for a capital raise alongside the upcoming AQUASCOUT water testing device launch.

Universal Biosensors reported a 6% increase in revenue for Q1 2025 but posted a net loss of A$3.84 million, with cash reserves sufficient only through Q3 2025, raising questions about its financial sustainability.

ClearVue Technologies has inked a five-year exclusive manufacturing and distribution agreement with New Zealand’s Viridian Glass, marking its strategic entry into the New Zealand market with solar-integrated glazing solutions.

TasFoods reported a $10.7 million net loss for FY2024, challenged by an oversupplied poultry market and a significant asset impairment. The company is pivoting towards growth in pet treats and dairy exports to stabilize its future.